Published in Virologie on May 02, 1986
Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck. Proc Natl Acad Sci U S A (1984) 2.87
Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature (1990) 2.61
Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori. Eur J Clin Microbiol Infect Dis (1993) 2.02
Core antigen and antibody in woodchucks after infection with woodchuck hepatitis virus. J Virol (1984) 1.97
Helicobacter pylori seropositivity in myocardial infarction. Lancet (1995) 1.81
Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann Intern Med (1984) 1.74
Helicobacter pylori: host responses in peptic ulceration. Lancet (1993) 1.73
Chronic Helicobacter pylori infection and migraine: a case-control study. Headache (2001) 1.54
Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts. Lancet (1982) 1.50
Incidence of hepatitis delta virus infection in acute HBsAg-negative hepatitis. J Infect Dis (1989) 1.48
Family treatment of symptomatic children with Helicobacter pylori infection. Ital J Gastroenterol Hepatol (1997) 1.41
Re: Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst (1996) 1.41
Hepadnavirus integration: mechanisms of activation of the N-myc2 retrotransposon in woodchuck liver tumors. J Virol (1992) 1.34
Properties of delta-associated ribonucleic acid. Prog Clin Biol Res (1983) 1.34
Hepatitis delta virus (HDV) and woodchuck hepatitis virus (WHV) nucleic acids in tissues of HDV-infected chronic WHV carrier woodchucks. J Virol (1989) 1.26
Precursor 16S RNA in active 30S ribosomes. Nature (1974) 1.25
Experimental transmission of the delta agent to chimpanzees. Prog Clin Biol Res (1983) 1.21
Evidence for replication of hepatitis delta virus RNA in hepatocyte nuclei after in vivo infection. Virology (1988) 1.17
An ultrastructural and immunohistochemical study on the delta antigen associated with the hepatitis B virus. J Pathol (1979) 1.16
Antigenic analysis of woodchuck hepatitis virus surface antigen with site-specific radioimmunoassays. J Virol (1984) 1.15
Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro. Hepatology (1997) 1.15
Radioimmunoassay and characterization of woodchuck hepatitis virus core antigen and antibody. Virus Res (1985) 1.13
Titration of the infectivity of hepatitis D virus in chimpanzees. J Infect Dis (1987) 1.11
Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. J Hepatol (2000) 1.04
Role of hepatitis delta virus infection in hepatocellular carcinoma. Dig Dis Sci (1991) 1.02
Histologic studies of severe delta agent infection in Venezuelan Indians. Hepatology (1983) 1.02
Cell-mediated immunity to acetaldehyde in alcoholic liver disease demonstrated by leukocyte migration test. Am J Dig Dis (1978) 1.01
Epidemiology of hepatitis delta virus (HDV) infection. Eur J Epidemiol (1985) 1.00
The human bone-marrow-derived B-cell line CE, susceptible to hepatitis C virus infection. Res Virol (1993) 1.00
HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection? Arch Intern Med (1995) 0.98
Extended lymph node dissection for gastric cancer: results of a prospective, multi-centre analysis of morbidity and mortality in 118 consecutive cases. Eur J Surg Oncol (1997) 0.96
Cytoplasmic tubular structures in liver of HBsAg carrier chimpanzees infected with delta agent and comparison with cytoplasmic structures in non-A, non-B hepatitis. Hepatology (1983) 0.95
Proteins of hepatitis delta virus. Prog Clin Biol Res (1987) 0.95
Replication and multiplication of hepatitis C virus genome in human foetal liver cells. Res Virol (1993) 0.95
Hepatitis B markers in United States drug addicts with special emphasis on the delta hepatitis virus. Hepatology (1985) 0.94
Helicobacter pylori and stomach cancer: a case-control study in Venezuela. Cancer Epidemiol Biomarkers Prev (2000) 0.93
Ribosome biosynthesis in Escherichia coli. Concerning the limiting step. Biochemistry (1974) 0.92
Histogenesis of primary liver carcinomas: strengths and weaknesses of cytokeratin profile and albumin mRNA detection. Hum Pathol (1996) 0.92
Prevalence of the hepatitis delta virus in Rumania. Hepatogastroenterology (1986) 0.92
The significance of infections with two types of viral hepatitis demonstrated by histologic features in chimpanzees. J Hepatol (1990) 0.92
MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine. Cell Mol Life Sci (2013) 0.91
Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: its specific receptor c-met does. Hepatology (1996) 0.91
Susceptibility of human liver cell cultures to hepatitis C virus infection. Arch Virol Suppl (1993) 0.91
Delta agent in Britain. Lancet (1983) 0.90
Hepatitis delta virus as a global health problem. Vaccine (1990) 0.90
The journey from hepatitis to hepatocellular carcinoma. Bridging role of Helicobacter species. Panminerva Med (2001) 0.88
[Gastroenterology outpatient clinic of the Molinette Hospital (Turin, Italy): the 2003-2006 report]. Minerva Med (2007) 0.88
Deeper insight into HBsAg--anti-albumin antibody correlations. J Med Virol (1979) 0.87
Helicobacter pylori infection and infertility. Eur J Gastroenterol Hepatol (2002) 0.87
Detection of helicobacter candidatus suis by PCR in oesophagogastric ulcers of swine in Italy. Acta Vet Hung (2006) 0.86
Nucleotide sequence analysis of three different hepatitis delta viruses isolated from a woodchuck and humans. J Gen Virol (1991) 0.86
Overexpression of c-met protooncogene product and raised Ki67 index in hepatocellular carcinomas with respect to benign liver conditions. Hepatology (1995) 0.86
Acute myocardial infarction and Helicobacter pylori seropositivity. Int J Clin Lab Res (1999) 0.85
Ultrastructural observations of viral particles within hepatitis C virus-infected human B lymphoblastoid cell line. Res Virol (1997) 0.85
Experimental hepatitis delta virus infection in the chimpanzee. Prog Clin Biol Res (1987) 0.84
A solid-phase enzyme immunoassay (EIA) for detection of HBeAg and anti-HBe. J Immunol Methods (1980) 0.84
Epidemiology of hepatitis delta virus: overview. Prog Clin Biol Res (1991) 0.83
Elevated serum chromogranin A in patients with hepatocellular carcinoma. Clin Exp Med (2002) 0.83
Amplification of hepatitis delta virus RNA sequences by polymerase chain reaction: a tool for viral detection and cloning. Mol Cell Probes (1990) 0.83
Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. The Como cross-sectional study. Panminerva Med (2001) 0.83
New high-performance liquid chromatographic method for the detection of picolinic acid in biological fluids. J Chromatogr B Biomed Sci Appl (2001) 0.83
Mixed cryoglobulinaemia and chronic hepatitis C virus infection: the rheumatic manifestations. J Med Virol (2002) 0.82
Does delta agent contribute to fulminant hepatitis? Lancet (1983) 0.82
HCV infection by cell-to-cell transmission: choice or necessity? Curr Mol Med (2012) 0.81
Antibody to the hepatitis B virus-associated delta-agent in immune serum globulins. Gastroenterology (1984) 0.81
HCV infective virions can be carried by human platelets. Cell Biochem Funct (2004) 0.81
Adenine arabinoside monophosphate coupled to lactosaminated human albumin administered for 4 weeks in patients with chronic type B hepatitis decreased viremia without producing significant side effects. Hepatology (1996) 0.81
Hepatitis delta virus infection in Pekin ducks chronically infected by the duck hepatitis B virus. Prog Clin Biol Res (1987) 0.81
Sub-epitopic dissection of HCV E1315-328HRMAWDMMMNWSPT sequence by similarity analysis. Amino Acids (2007) 0.80
Worldwide epidemiology and modes of transmission of delta hepatitis. Infection (1987) 0.80
Helicobacter pylori: from the stomach to the heart. Eur J Gastroenterol Hepatol (1999) 0.80
Chronic active hepatitis B. Interferon-activated natural killer-like cells against a hepatoma cell line transfected with the hepatitis B virus nucleic acid. Liver (1991) 0.80
Immunization of woodchucks with recombinant hepatitis delta antigen does not protect against hepatitis delta virus infection. Hepatology (1990) 0.80
Superimposed hepatitis and the effect on viral replication in chronic hepatitis B. J Hepatol (1986) 0.80
Different outcomes of chronic hepatitis delta virus infection in woodchucks. Liver (1990) 0.79
Acute and chronic delta infection in the woodchuck. Prog Clin Biol Res (1987) 0.79
Helicobacter pylori seropositivity in patients with unstable angina. J Cardiovasc Surg (Torino) (2003) 0.79
Infection by Helicobacter pylori and acute myocardial infarction. Do cytotoxic strains make a difference? New Microbiol (2002) 0.79
Multiple rearrangements and activated expression of c-myc induced by woodchuck hepatitis virus integration in a primary liver tumour. Res Virol (1992) 0.78
Serological diagnosis of acute viral hepatitis. Dig Dis Sci (1985) 0.78
Helicobacter pylori screening and gastric cancer. Lancet (1996) 0.78
Strategies for successful vaccination against hepatocellular carcinoma. Int J Immunopathol Pharmacol (2009) 0.78
[Ischemic cardiovascular diseases. Correlation with Helicobacter pylori infection]. Minerva Cardioangiol (2000) 0.78
The woodchuck animal model of hepatitis B-like virus infection and disease. Prog Clin Biol Res (1983) 0.77
Ischemic cardiovascular disease and Helicobacter pylori. Where is the link? J Cardiovasc Surg (Torino) (2000) 0.77
The effects of using recombinant vaccinia viruses expressing either large or small HDAg to protect woodchuck hepadnavirus carriers from HDV superinfection. Prog Clin Biol Res (1993) 0.77
Hepatotoxicity of intravenous cyclosporin A in patients with acute ulcerative colitis on total parenteral nutrition. Liver (1995) 0.77
Gastro-oesophageal reflux disease and asthma: would be possible to improve therapy on the basis of what is now known? Panminerva Med (2004) 0.77
Patients with acute myocardial infarction in northern Italy are often infected by Helicobacter pylori. Panminerva Med (1999) 0.77
Campylobacter pylori in families of children with relapsing gastroduodenal disease due to C. pylori infection. Am J Gastroenterol (1988) 0.77
Epidemiology of hepatitis B and delta virus infection in Albania: an approach to universal vaccination. Res Virol (1996) 0.77
[Infections and cardiovascular diseases on an ischemic basis. The case of Helicobacter pylori]. Minerva Med (2001) 0.77
Delta hepatitis virus infection in Ethiopia. Eur J Epidemiol (1988) 0.77
Previous tuberculosis, hepatitis C virus and lichen planus. A report of 10 cases, a causal or casual link? Panminerva Med (2000) 0.76
[The exacerbation of psoriasis during treatment with alfa interferon]. Recenti Prog Med (1997) 0.76
[Intestinal metaplasia, dysplasia, gastric cancer and Helicobacter pylori: epidemiological observations]. Minerva Med (2005) 0.76
HDV infection from blood and blood products. Prog Clin Biol Res (1987) 0.76
Prevalence of delta antibodies among urban HBsAg-positive chronic liver disease patients in Egypt. Hepatogastroenterology (1988) 0.76
[Simultaneous inoculation of hepatitis B virus and non-A non-B agents on a chimpanzee: histopathology in relation to electron microscopic and immunologic findings]. Verh Dtsch Ges Pathol (1981) 0.75